An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Investigational Drug Acquiring Popularity Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these profiles privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before directing customers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Express Concerns
However, doctors and chemists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.
Some professionals stated the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.
Service Response and Material Removal
According to the social media company, the platform has removed violative content and banned related keywords and query recommendations. The organization said it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also found communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, positive testimonials and step-by-step guides for mixing or injecting at residence.
After moments of entering one community, a vendor shared WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, health issues or previous experience.
Item Details and Costs
Inside these communities, messages display dark colored packages with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they cannot confirm. Even if the science behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has previously seen individuals harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to possibly significant health risks”.
